The Effect of Virtual Reality on Women Undergoing Hysterosalpingography

January 19, 2023 updated by: NESLİHAN YILMAZ SEZER

The Effect of Virtual Reality On Women's Perceptıons of Fear, Pain, Anxiety and Satisfaction Undergoing Hysterosalpingography; A Randomized Controlled Research

The aim of this study is to determine the effect of virtual reality on perceived pain, anxiety, fear, physiological reactions and satisfaction in women during the HSG procedure.

Hypotheses H01; In the HSG procedure, there was no difference between the pain score of the virtual reality group and the pain score of the control group.

H02; In the HSG procedure, there was no difference between the anxiety score of the virtual reality group and the anxiety score of the control group.

H03; In the HSG procedure, there was no difference between the satisfaction score of the virtual reality group and the satisfaction score of the control group.

H04; In the HSG procedure, there was no difference between the vital signs of the virtual reality group and the control group.

H05; In the HSG procedure, there was no difference between the fear score of the virtual reality group and the fear score of the control group.

The study will be carried out in two different groups. The practice will start with meeting the women who apply to the Radiology clinic for an HSG. After the women are evaluated in terms of eligibility criteria for the research, the women who are eligible will be informed about the research and written informed consent will be obtained from the women who accept. The random distribution of women to the study groups will be carried out using the Block Randomization method. The following applications will be made to the groups.

Virtual Reality Group In addition to the routine procedure, virtual reality glasses will be applied to the women in the virtual reality group of the research. Virtual reality glasses is a device that works on compatible smart mobile phones. After being taken to the gynecological table for the HSG procedure, the women included in the experimental group will be made to watch a video lasting an average of 10 minutes with virtual reality glasses until the procedure is completed. While watching the video, the relaxing music of the video will be played in the practice room with a bluetooth speaker.

Control Group Patients in the control group of the study will not be subjected to any treatment other than the routine procedure.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06100
        • Ankara University Fertility Diagnosis, Treatment, Research and Application Center
    • Mamak
      • Ankara, Mamak, Turkey, 06100
        • Ankara University Fertility Diagnosis, Treatment, Research and Application Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • primary infertility
  • Agreeing to participate in the research and obtaining written permission,
  • No hearing or vision problems
  • The first time HSG procedure will be applied

Exclusion Criteria:

  • Didn't watch the whole video
  • Those with motion-sensitive diseases such as vertigo, meniere
  • Using any pharmacological pain-reducing method within 30 minutes
  • Difficulty in the HSG process or completing the process with more than one attempt
  • Use of antidepressants or sedatives
  • Any history of allergy to radio-opaque dye

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Virtual Reality Group
In addition to the routine procedure, virtual reality glasses will be applied to the women in the virtual reality group of the research. Virtual reality glasses is a device that works on compatible smart mobile phones. After being taken to the gynecological table for the HSG procedure, the women included in the experimental group will be made to watch a video lasting an average of 10 minutes with virtual reality glasses until the procedure is completed. While watching the video, the relaxing music of the video will be played.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in anxiety
Time Frame: immediately before the HSG procedure and immediately after the HSG procedure
STAI-S consist of 20 items with four points Likert scales, each (not at all, somewhat, moderately so, very much so). Scores thus range between 20, indicating a low level of anxiety and 80, indicating a high level.
immediately before the HSG procedure and immediately after the HSG procedure
Change in the degree of pain experienced during the procedure
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
The pain was assessed using 0-100 mm VAS for determining perceptions of pain during the procedure. This scale is widely used and has demonstrated reliability and validity in the measurement of acute pain. A high score on the scale indicated a high level of pain and a score of 0 pointed to no pain at all (Bijur, Silver, & Gallagher, 2001). Each participant was asked to mark her current level of perceived pain along the scale, with the number corresponding to the marked point recorded as the pain score
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
Change in fear
Time Frame: immediately before the HSG procedure, immediately after the HSG procedure, and 15 minutes after the HSG procedure
VAS is a 10-cm-long measurement tool. The left end of the scale reads "no fear at all" and the right end reads "the most intense fear possible". A high score on the scale indicated a high level of fear and a score of 0 pointed to no fear.
immediately before the HSG procedure, immediately after the HSG procedure, and 15 minutes after the HSG procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the degree of satisfaction
Time Frame: 15 minutes after the HSG procedure
VAS is a 10-cm-long measurement tool. The left end of the scale reads "I am not satisfied at all" and the right end reads "very satisfied". A high score on the scale indicated a high level of satisfied and a score of 0 pointed to no satisfied.
15 minutes after the HSG procedure
Change in blood pressure
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
mmHg
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
Change in heart rate
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
beats per minute (bpm)
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
Change in body temperature
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
degrees Celsius
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
Change in the saturation of peripheral oxygen SpO2
Time Frame: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure
HSG result
Time Frame: 15 minutes after the HSG procedure
both tubes patent, one fallopian tubes occluded, both fallopian tubes occluded
15 minutes after the HSG procedure
contrast medium volume
Time Frame: during HSG prosedure
milliliter (ml)
during HSG prosedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 26, 2022

Primary Completion (Actual)

June 30, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

March 14, 2022

First Submitted That Met QC Criteria

April 1, 2022

First Posted (Actual)

April 6, 2022

Study Record Updates

Last Update Posted (Actual)

January 20, 2023

Last Update Submitted That Met QC Criteria

January 19, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 04/49

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hysterosalpingography

Clinical Trials on Virtual Reality

3
Subscribe